AbbVie
ABBV
#28
Rank
$273.97 B
Marketcap
$155.30
Share price
1.06%
Change (1 day)
-1.97%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2022 (TTM): $13.47 B

According to AbbVie's latest financial reports the company's current earnings (TTM) are $13.47 B. In 2021 the company made an earning of $12.98 B an increase over its 2020 earnings that were of $3.39 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$13.47 B3.76%
2021$12.98 B282.25%
2020$3.39 B-59.67%
2019$8.42 B62.13%
2018$5.19 B-32.74%
2017$7.72 B-1.99%
2016$7.88 B18.65%
2015$6.64 B180.5%
2014$2.36 B-55.57%
2013$5.33 B-6.86%
2012$5.72 B56.05%
2011$3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$35.96 B 166.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.80 B-49.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.34 B-45.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.59 B-73.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.81 B-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.71 B-42.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.83 B-71.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.60 B-43.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.22 B-98.36%๐Ÿ‡บ๐Ÿ‡ธ USA